Rizza G, Glynou K, Eletskaya M
World J Transplant. 2024; 14(3):90949.
PMID: 39295979
PMC: 11317858.
DOI: 10.5500/wjt.v14.i3.90949.
Kumar N, Choudhary N
J Clin Exp Hepatol. 2023; 14(2):101287.
PMID: 38076445
PMC: 10709521.
DOI: 10.1016/j.jceh.2023.09.008.
Burm R, Van Houtte F, Verhoye L, Mesalam A, Ciesek S, Roingeard P
JHEP Rep. 2023; 5(3):100646.
PMID: 36748051
PMC: 9898450.
DOI: 10.1016/j.jhepr.2022.100646.
Roche B, Bauhofer A, Gomez Bravo M, Pageaux G, Zoulim F, Otero A
Ann Transplant. 2022; 27:e936162.
PMID: 35534995
PMC: 9107284.
DOI: 10.12659/AOT.936162.
Akarsu M, Onem S, Turan I, Adali G, Akdogan M, Akyildiz M
Turk J Gastroenterol. 2021; 32(9):712-719.
PMID: 34609299
PMC: 8975456.
DOI: 10.5152/tjg.2021.21608.
Prevention of HBV Recurrence after Liver Transplant: A Review.
Nasir M, Wu G
J Clin Transl Hepatol. 2020; 8(2):150-160.
PMID: 32832395
PMC: 7438351.
DOI: 10.14218/JCTH.2020.00003.
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation.
Volpes R, Burra P, Germani G, Manini M, Caccamo L, Strignano P
Health Qual Life Outcomes. 2020; 18(1):99.
PMID: 32276633
PMC: 7149917.
DOI: 10.1186/s12955-020-01349-5.
Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
Ma Z, Zhang E, Gao S, Xiong Y, Lu M
Front Immunol. 2019; 10:2308.
PMID: 31608073
PMC: 6769125.
DOI: 10.3389/fimmu.2019.02308.
The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence.
Vatansever S, Farajov R, Yilmaz H, Zeytunlu M, Kilic M
Turk J Med Sci. 2019; 49(4):1019-1024.
PMID: 31385669
PMC: 7018359.
DOI: 10.3906/sag-1808-86.
A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.
Han S, Na G, Kim D
Drug Des Devel Ther. 2017; 11:2099-2107.
PMID: 28744101
PMC: 5513836.
DOI: 10.2147/DDDT.S134711.
Spontaneous resolution of de novo hepatitis B after living donor liver transplantation with hepatitis B core antibody positive graft: a case report.
Hara Y, Tokodai K, Nakanishi C, Miyagi S, Kawagishi N
Surg Case Rep. 2016; 2(1):118.
PMID: 27797067
PMC: 5083705.
DOI: 10.1186/s40792-016-0246-2.
The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A, Imamura M, Tsuge M, Kan H, Fujino H, Fukuhara T
J Gastroenterol. 2016; 52(3):366-375.
PMID: 27422771
DOI: 10.1007/s00535-016-1240-y.
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV).
Welker M, Zeuzem S
Visc Med. 2016; 32(2):105-9.
PMID: 27413727
PMC: 4926884.
DOI: 10.1159/000445152.
High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee E, Kim S, Lee S, Park H, Lee S, Park S
World J Gastroenterol. 2016; 22(14):3803-12.
PMID: 27076765
PMC: 4814743.
DOI: 10.3748/wjg.v22.i14.3803.
Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation.
Maiwall R, Kumar M
J Clin Transl Hepatol. 2016; 4(1):54-65.
PMID: 27047773
PMC: 4807144.
DOI: 10.14218/JCTH.2015.00041.
Management of hepatitis B virus infection after liver transplantation.
Jimenez-Perez M, Gonzalez-Grande R, Mostazo Torres J, Gonzalez Arjona C, Rando-Munoz F
World J Gastroenterol. 2015; 21(42):12083-90.
PMID: 26576093
PMC: 4641126.
DOI: 10.3748/wjg.v21.i42.12083.
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.
Ishigami M, Ogura Y, Hirooka Y, Goto H
World J Gastroenterol. 2015; 21(36):10290-8.
PMID: 26420956
PMC: 4579876.
DOI: 10.3748/wjg.v21.i36.10290.
Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?.
Harmanci O, Selcuk H, Haberal M
J Clin Transl Hepatol. 2015; 2(4):259-65.
PMID: 26356785
PMC: 4521236.
DOI: 10.14218/JCTH.2014.00023.
Immune-mediated Liver Injury in Hepatitis B Virus Infection.
Oh I, Park S
Immune Netw. 2015; 15(4):191-8.
PMID: 26330805
PMC: 4553257.
DOI: 10.4110/in.2015.15.4.191.
Management of chronic hepatitis B before and after liver transplantation.
Fung J
World J Hepatol. 2015; 7(10):1421-6.
PMID: 26052387
PMC: 4450205.
DOI: 10.4254/wjh.v7.i10.1421.
